MARKET

AMRN

AMRN

Amarin
NASDAQ
0.5486
+0.0237
+4.52%
After Hours: 0.5501 +0.0015 +0.27% 19:07 11/22 EST
OPEN
0.5300
PREV CLOSE
0.5249
HIGH
0.5600
LOW
0.5205
VOLUME
1.37M
TURNOVER
--
52 WEEK HIGH
1.370
52 WEEK LOW
0.4565
MARKET CAP
225.66M
P/E (TTM)
-5.7205
1D
5D
1M
3M
1Y
5Y
1D
AMARIN CORP - NASDAQ GRANTED 180 DAYS TO REGAIN NASDAQ COMPLIANCE
Reuters · 10h ago
After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin (AMRN)
NASDAQ · 3d ago
Top 3 Health Care Stocks You'll Regret Missing In Q4
Benzinga · 3d ago
Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), Bolt Biotherapeutics (BOLT) and Amarin (AMRN)
TipRanks · 4d ago
Weekly Report: what happened at AMRN last week (1111-1115)?
Weekly Report · 4d ago
Amarin Corporation Announces That Investigators Will Present An Additional Subgroup Analysis From The REDUCE-IT Outcomes Trial In Patients With And Without Coronary Artery Disease History And Mechanistic Data On Eicosapentaenoic Acid At The American Heart Association's Scientific Sessions
Benzinga · 11/11 13:22
Amarin announces to present additional analysis from REDUCE-IT outcomes trial
TipRanks · 11/11 13:22
Weekly Report: what happened at AMRN last week (1104-1108)?
Weekly Report · 11/11 09:53
More
About AMRN
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.

Webull offers Amarin Corporation plc (ADR) stock information, including NASDAQ: AMRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMRN stock methods without spending real money on the virtual paper trading platform.